Search - tctmd.com

Displaying 521 - 540 of 795

Sort: Relevancy | Date

Presentation CCVVC 2015

Covered Stents in Femoropopliteal Disease

Presenter: Subhash Banerjee

June 18, 2015

Presentation Fellows 2015

Drug-Eluting Stents: Past, Present, and Future

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation CHIP Florida 2015

PCI for Bifurcations:The Menu when 2 Stents are Needed

Presenter: Philippe Généreux

March 13, 2015

Presentation

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

Presenter: A.Puricel

February 26, 2015

Presentation

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Presenter: Marco Valgimigli

February 23, 2015

Presentation ISET 2015

Retrievable Stents: Technique and Results

Presenter: Italo Linfante

January 30, 2015

Presentation

Impact of Thrombus Burden on Outcomes After Standard Versus Mesh-Covered Stents in AMI

Presenter: Ricardo A. Costa

November 30, 2014

Presentation AHA 2014

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

Presenter: C.Kaiser

November 16, 2014

Presentation

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Presenter: M.K. Lam

October 31, 2014

Presentation VEINS 2014

How Grafts, Stents, Balloons Affect Lower Extremity Testing

Presenter: Raghu Kolluri

October 09, 2014

Presentation TCT 2014

An Algorithm to Choose Between 1 vs 2 Stents in the Left Main (and Which 2-Stent Technique)

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Jean Fajadet

September 16, 2014

Presentation TCT 2014

Choice of Metallic DES Stents for Left Main Bifurcation Stenting: Are Some More Equal Than Others?

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Nicolas Foin

September 16, 2014

Presentation TCT 2014

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Ron Waksman

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

Case #6: BRS: One Scaffold vs Two Scaffolds/Stents

Presenter: Shao Liang Chen, Issam D. Moussa, Leif Thuesen, Jean Fajadet

September 16, 2014

Presentation TCT 2014

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Stephane Cook

September 16, 2014

Presentation TCT 2014

Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Presenter: Armando P?rez de Prado

September 16, 2014

Presentation TCT 2014

Drug Eluting Stents Versus Coronary Artery Bypass Graft surgery for Isolated Proximal Left Anterior Descending Artery Stenosis: A Meta-analysis

Presenter: Alok Saurav

September 16, 2014

Advertisement

Covered Stents in Femoropopliteal Disease

Drug-Eluting Stents: Past, Present, and Future

PCI for Bifurcations:The Menu when 2 Stents are Needed

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Retrievable Stents: Technique and Results

Impact of Thrombus Burden on Outcomes After Standard Versus Mesh-Covered Stents in AMI

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

How Grafts, Stents, Balloons Affect Lower Extremity Testing

An Algorithm to Choose Between 1 vs 2 Stents in the Left Main (and Which 2-Stent Technique)

Choice of Metallic DES Stents for Left Main Bifurcation Stenting: Are Some More Equal Than Others?

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Case #6: BRS: One Scaffold vs Two Scaffolds/Stents

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Drug Eluting Stents Versus Coronary Artery Bypass Graft surgery for Isolated Proximal Left Anterior Descending Artery Stenosis: A Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content